HeartSciences Inc.
HSCSNASDAQHealthcareMedical Devices

About HeartSciences

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Company Information

CEOAndrew Simpson
Founded2007
IPO DateJune 15, 2022
Employees15
CountryUnited States
Fiscal YearMay - April

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone682 237 7781
Address
550 Reserve Street, Suite 360 Southlake, Texas 76092 United States

Corporate Identifiers

CIK0001468492
CUSIP42254E104
ISINUS42254E3027
EIN26-1344466
SIC3842

Leadership Team & Key Executives

Andrew Simpson
Chief Executive Officer, President and Chairman of the Board of Directors
Danielle Watson
Chief Financial Officer and Treasurer
Mark T. Hilz
Chief Operating Officer, Secretary and Director